Correction to: Discovery of a novel third-generation EGFR inhibitor and identification of a potential combination strategy to overcome resistance

Bibliographic Details
Main Authors: Tao Zhang, Rong Qu, Shingpan Chan, Mengzhen Lai, Linjiang Tong, Fang Feng, Hongyu Chen, Tingting Song, Peiran Song, Gang Bai, Yingqiang Liu, Yanan Wang, Yan Li, Yi Su, Yanyan Shen, Yiming Sun, Yi Chen, Meiyu Geng, Ke Ding, Jian Ding, Hua Xie
Format: Article
Language:English
Published: BMC 2021-08-01
Series:Molecular Cancer
Online Access:https://doi.org/10.1186/s12943-021-01391-x
id doaj-8f88e3c675584ea49330aba5383f0cc5
record_format Article
spelling doaj-8f88e3c675584ea49330aba5383f0cc52021-08-22T11:03:28ZengBMCMolecular Cancer1476-45982021-08-012011110.1186/s12943-021-01391-xCorrection to: Discovery of a novel third-generation EGFR inhibitor and identification of a potential combination strategy to overcome resistanceTao Zhang0Rong Qu1Shingpan Chan2Mengzhen Lai3Linjiang Tong4Fang Feng5Hongyu Chen6Tingting Song7Peiran Song8Gang Bai9Yingqiang Liu10Yanan Wang11Yan Li12Yi Su13Yanyan Shen14Yiming Sun15Yi Chen16Meiyu Geng17Ke Ding18Jian Ding19Hua Xie20Division of Antitumor Pharmacology, State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of SciencesDivision of Antitumor Pharmacology, State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of SciencesInternational Cooperative Laboratory of Traditional Chinese Medicine Modernization and Innovative Drug Development of Chinese Ministry of Education (MOE), Guangzhou City Key Laboratory of Precision Chemistry Drug Development, School of Pharmacy, Jinan UniversityDivision of Antitumor Pharmacology, State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of SciencesDivision of Antitumor Pharmacology, State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of SciencesDivision of Antitumor Pharmacology, State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of SciencesJiangsu Aosaikang Pharmaceutical Co.Ltd (ASK pharm)Jiangsu Aosaikang Pharmaceutical Co.Ltd (ASK pharm)Division of Antitumor Pharmacology, State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of SciencesDivision of Antitumor Pharmacology, State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of SciencesDivision of Antitumor Pharmacology, State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of SciencesDivision of Antitumor Pharmacology, State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of SciencesDivision of Antitumor Pharmacology, State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of SciencesDivision of Antitumor Pharmacology, State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of SciencesDivision of Antitumor Pharmacology, State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of SciencesDivision of Antitumor Pharmacology, State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of SciencesDivision of Antitumor Pharmacology, State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of SciencesDivision of Antitumor Pharmacology, State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of SciencesInternational Cooperative Laboratory of Traditional Chinese Medicine Modernization and Innovative Drug Development of Chinese Ministry of Education (MOE), Guangzhou City Key Laboratory of Precision Chemistry Drug Development, School of Pharmacy, Jinan UniversityDivision of Antitumor Pharmacology, State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of SciencesDivision of Antitumor Pharmacology, State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Scienceshttps://doi.org/10.1186/s12943-021-01391-x
collection DOAJ
language English
format Article
sources DOAJ
author Tao Zhang
Rong Qu
Shingpan Chan
Mengzhen Lai
Linjiang Tong
Fang Feng
Hongyu Chen
Tingting Song
Peiran Song
Gang Bai
Yingqiang Liu
Yanan Wang
Yan Li
Yi Su
Yanyan Shen
Yiming Sun
Yi Chen
Meiyu Geng
Ke Ding
Jian Ding
Hua Xie
spellingShingle Tao Zhang
Rong Qu
Shingpan Chan
Mengzhen Lai
Linjiang Tong
Fang Feng
Hongyu Chen
Tingting Song
Peiran Song
Gang Bai
Yingqiang Liu
Yanan Wang
Yan Li
Yi Su
Yanyan Shen
Yiming Sun
Yi Chen
Meiyu Geng
Ke Ding
Jian Ding
Hua Xie
Correction to: Discovery of a novel third-generation EGFR inhibitor and identification of a potential combination strategy to overcome resistance
Molecular Cancer
author_facet Tao Zhang
Rong Qu
Shingpan Chan
Mengzhen Lai
Linjiang Tong
Fang Feng
Hongyu Chen
Tingting Song
Peiran Song
Gang Bai
Yingqiang Liu
Yanan Wang
Yan Li
Yi Su
Yanyan Shen
Yiming Sun
Yi Chen
Meiyu Geng
Ke Ding
Jian Ding
Hua Xie
author_sort Tao Zhang
title Correction to: Discovery of a novel third-generation EGFR inhibitor and identification of a potential combination strategy to overcome resistance
title_short Correction to: Discovery of a novel third-generation EGFR inhibitor and identification of a potential combination strategy to overcome resistance
title_full Correction to: Discovery of a novel third-generation EGFR inhibitor and identification of a potential combination strategy to overcome resistance
title_fullStr Correction to: Discovery of a novel third-generation EGFR inhibitor and identification of a potential combination strategy to overcome resistance
title_full_unstemmed Correction to: Discovery of a novel third-generation EGFR inhibitor and identification of a potential combination strategy to overcome resistance
title_sort correction to: discovery of a novel third-generation egfr inhibitor and identification of a potential combination strategy to overcome resistance
publisher BMC
series Molecular Cancer
issn 1476-4598
publishDate 2021-08-01
url https://doi.org/10.1186/s12943-021-01391-x
work_keys_str_mv AT taozhang correctiontodiscoveryofanovelthirdgenerationegfrinhibitorandidentificationofapotentialcombinationstrategytoovercomeresistance
AT rongqu correctiontodiscoveryofanovelthirdgenerationegfrinhibitorandidentificationofapotentialcombinationstrategytoovercomeresistance
AT shingpanchan correctiontodiscoveryofanovelthirdgenerationegfrinhibitorandidentificationofapotentialcombinationstrategytoovercomeresistance
AT mengzhenlai correctiontodiscoveryofanovelthirdgenerationegfrinhibitorandidentificationofapotentialcombinationstrategytoovercomeresistance
AT linjiangtong correctiontodiscoveryofanovelthirdgenerationegfrinhibitorandidentificationofapotentialcombinationstrategytoovercomeresistance
AT fangfeng correctiontodiscoveryofanovelthirdgenerationegfrinhibitorandidentificationofapotentialcombinationstrategytoovercomeresistance
AT hongyuchen correctiontodiscoveryofanovelthirdgenerationegfrinhibitorandidentificationofapotentialcombinationstrategytoovercomeresistance
AT tingtingsong correctiontodiscoveryofanovelthirdgenerationegfrinhibitorandidentificationofapotentialcombinationstrategytoovercomeresistance
AT peiransong correctiontodiscoveryofanovelthirdgenerationegfrinhibitorandidentificationofapotentialcombinationstrategytoovercomeresistance
AT gangbai correctiontodiscoveryofanovelthirdgenerationegfrinhibitorandidentificationofapotentialcombinationstrategytoovercomeresistance
AT yingqiangliu correctiontodiscoveryofanovelthirdgenerationegfrinhibitorandidentificationofapotentialcombinationstrategytoovercomeresistance
AT yananwang correctiontodiscoveryofanovelthirdgenerationegfrinhibitorandidentificationofapotentialcombinationstrategytoovercomeresistance
AT yanli correctiontodiscoveryofanovelthirdgenerationegfrinhibitorandidentificationofapotentialcombinationstrategytoovercomeresistance
AT yisu correctiontodiscoveryofanovelthirdgenerationegfrinhibitorandidentificationofapotentialcombinationstrategytoovercomeresistance
AT yanyanshen correctiontodiscoveryofanovelthirdgenerationegfrinhibitorandidentificationofapotentialcombinationstrategytoovercomeresistance
AT yimingsun correctiontodiscoveryofanovelthirdgenerationegfrinhibitorandidentificationofapotentialcombinationstrategytoovercomeresistance
AT yichen correctiontodiscoveryofanovelthirdgenerationegfrinhibitorandidentificationofapotentialcombinationstrategytoovercomeresistance
AT meiyugeng correctiontodiscoveryofanovelthirdgenerationegfrinhibitorandidentificationofapotentialcombinationstrategytoovercomeresistance
AT keding correctiontodiscoveryofanovelthirdgenerationegfrinhibitorandidentificationofapotentialcombinationstrategytoovercomeresistance
AT jianding correctiontodiscoveryofanovelthirdgenerationegfrinhibitorandidentificationofapotentialcombinationstrategytoovercomeresistance
AT huaxie correctiontodiscoveryofanovelthirdgenerationegfrinhibitorandidentificationofapotentialcombinationstrategytoovercomeresistance
_version_ 1721200100901912576